CPFX2090
CPFX2090 is a cephalosporin antibacterial compound extracted from patent WO2013052568A1, Compound Example 16g.
For research use only. We do not sell to patients.
- CAS No.: 1429439-25-7
- Formula: C28H28ClNO6
- Molecular Weight:509.98
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Chemical Information
-
CAS No. 1429439-25-7
-
Molecular Weight 509.98
-
Formula C28H28ClNO6
-
SMILES
O=C1C(CO)=CN(CC)C2=C1C(Cl)=C(OCC3=CC=C(OC)C=C3)C(OCC4=CC=C(OC)C=C4)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
In Vitro:
DMSO : 25 mg/mL (49.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
References
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9609 mL | 9.8043 mL | 19.6086 mL | 49.0215 mL |
| 5 mM | 0.3922 mL | 1.9609 mL | 3.9217 mL | 9.8043 mL | |
| 10 mM | 0.1961 mL | 0.9804 mL | 1.9609 mL | 4.9022 mL | |
| 15 mM | 0.1307 mL | 0.6536 mL | 1.3072 mL | 3.2681 mL | |
| 20 mM | 0.0980 mL | 0.4902 mL | 0.9804 mL | 2.4511 mL | |
| 25 mM | 0.0784 mL | 0.3922 mL | 0.7843 mL | 1.9609 mL | |
| 30 mM | 0.0654 mL | 0.3268 mL | 0.6536 mL | 1.6341 mL | |
| 40 mM | 0.0490 mL | 0.2451 mL | 0.4902 mL | 1.2255 mL |
CPFX2090 Related Classifications
HY-135889 Related Classifications
Powered by Bioz